Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invyncible vs ShedRx

Invyncible
Site position #281

Lower grade

vs+23.4
ShedRx
Site position #3

Higher grade

The verdict

ShedRx takes it — 87/100 to 63.6/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueShedRx +39
45
84
Dose & formulationShedRx +18
78
96
Clinical oversightShedRx +14
70
84
Labs & monitoringShedRx +32
52
84
FulfillmentShedRx +15
73
88
Contract termsShedRx +8
77
85
Invyncible · left barShedRx · right bar

The numbers

MetricInvyncibleShedRx
WeighScore63.6/10087/100
GradeCB+
Site position#281#3
Semaglutide$149 starter program; supply length and refill cost need confirmation$199/mo
Tirzepatide$180 per 4-week starter program (2.5 mg weekly, compounded glycine + B12)$299/mo
CoverageVaries by formulation; glycine/B12 programs exclude AR, CA, IN, MN, OR and SCAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
Invyncible

Site position #281 · C

Strengths

  • Six pharmacies named with contact details
  • Patients can request a prescription copy or nominate a pharmacy
  • Public catalogs distinguish compounded products, brands and oral options
  • Refills are not automatic; payment is finalized only after physician approval

Where it loses points

  • Program amounts are not universal monthly prices; dose and formulation can change cost
  • Shipping cost not established on the reviewed program pages
  • State exclusions differ by formulation
  • Compounded medications are not FDA-approved
ShedRx

Site position #3 · B+

Strengths

  • Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
  • Brand Zepbound and Wegovy available beside the compounded line
  • Health coaching included with membership, plus a published 120-day weight-loss guarantee

Where it loses points

  • The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
  • The dispensing compounding pharmacy is not publicly named

Featured provider

ShedRx

ShedRx scores 87/100 (B+). The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard